Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Topical tofacitinib is a safe and effective treatment for autoimmune skin disorders.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

Oral minoxidil promotes hair growth but may cause side effects; needs monitoring.

Minoxidil, applied on the skin or taken orally, can improve hair growth in kids, but more research is needed due to possible side effects.

Low-dose oral minoxidil is generally safe for treating hair loss, with mostly mild side effects.

Using 2% tofacitinib cream with narrowband ultraviolet B improved facial vitiligo by 70% in patients who didn't respond to previous treatments, with no side effects reported.

Oral JAK inhibitors are safe for alopecia areata, but baricitinib may cause more acne and infections.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Tofacitinib helps mice grow more hair by increasing noggin and BMP4 levels, possibly better than minoxidil.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.

Oral minoxidil boosts hair growth and reduces shedding in androgenetic alopecia.

Baricitinib may effectively treat oral lichen planus.

Oral processed egg yolk improves hair regrowth and quality in alopecia patients.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Oral isotretinoína effectively stabilizes frontal fibrosing alopecia.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Tofacitinib may help treat severe hair loss, but more research is needed.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.